Quote this publication Share Print

Stereotactic Radiation Therapy for Liver Tumours - INAHTA Brief

-
Health technology assessment - Posted on Oct 10 2016

The purpose of this report was to analyse the efficacy and safety data of Stereotactic Body Radiation Therapy (SBRT) in patients with inoperable primary (hepatocellular carcinoma (HCC) and metastatic liver tumours (LM), to define the indications and the place of SBRT in the therapeutic strategy with the aim of its inclusion in the CCAM (French National list of reimbursement)

Contact Us

Évaluation des actes professionnels

See also